Salanee Kandandapani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Salanee Kandandapani has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Saad Tayyab
Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences, UCSI University
2 shared publications - Saharuddin Bin Mohamad
Institute of Biological Sciences, Faculty of Science, Universiti Malaya, Kuala Lumpur 50603, Malaysia
2 shared publications Amira Adlin Roslan
Biomolecular Research Group, Biochemistry Programme, Institute of Biological Sciences, Faculty of Science, University of Malaya, Kuala Lumpur, Malaysia
1 shared publication- Hafsa Tayyab
Faculty of Science, Bioinformatics Programme, Institute of Biological Sciences, University of Malaya, Kuala Lumpur, Malaysia
1 shared publication Nor Farrah Wahidah Ridzwan
Bioinformatics Programme, Institute of Biological Sciences, Faculty of Science, University of Malaya, Kuala Lumpur, Malaysia
1 shared publication- Zahirul Kabir
Department of Chemistry, University of Ostrava, 30. Dubna 22, 701 03, Ostrava, Czech Republic
1 shared publication
Latest Publications
- 1 January 2022
- Published by Croatian Chemical Society in Croatica Chemica Acta
- Vol. 95 (2) , P1-P12
Molecular Recognition between Anticancer Drug, Regorafenib and Human Serum Albumin: Interaction Revisited
The wet-lab techniques (fluorimetry and spectrophotometry), along with computational techniques (molecular docking and molecular dynamics (MD) simulation), were applied to re-examine the association of an anticancer drug, regorafenib (REG) with human...
- 1 January 2022
- Published by Croatian Chemical Society in Croatica Chemica Acta
- Vol. 95 (2) , P1-P12
Molecular Recognition between Anticancer Drug, Regorafenib and Human Serum Albumin: Interaction Revisited
The wet-lab techniques (fluorimetry and spectrophotometry), along with computational techniques (molecular docking and molecular dynamics (MD) simulation), were applied to re-examine the association of an anticancer drug, regorafenib (REG) with human...
- 20 November 2019
- Published by Springer Nature in Monatshefte für Chemie - Chemical Monthly
- Vol. 150 (12) , 2061-2070
Biophysical and computational approaches to unravel the molecular interaction mechanism of bromodeoxyuridine, a proliferative marker with human serum albumin
- 20 November 2019
- Published by Springer Nature in Monatshefte für Chemie - Chemical Monthly
- Vol. 150 (12) , 2061-2070
Biophysical and computational approaches to unravel the molecular interaction mechanism of bromodeoxyuridine, a proliferative marker with human serum albumin